116
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Expression and Clinical Value of Eukaryotic Translation Elongation Factor 1A1 (EEF1A1) in Diffuse Large B Cell Lymphoma

& ORCID Icon
Pages 7247-7258 | Published online: 27 Oct 2021

References

  • Martelli M, Ferreri AJM, Agostinelli C, et al. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013;87(2):146–171. doi:10.1016/j.critrevonc.2012.12.009
  • Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734. doi:10.1182/blood-2010-05-282632
  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166
  • Ma H, Luo X, Zhou P, et al. USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B-cell lymphoma. J Clin Lab Anal. 2021;35(3):e23693.
  • Thompson CA, Ghesquieres H, Maurer MJ, et al. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol. 2014;32(31):3506. doi:10.1200/JCO.2014.55.7561
  • Sanders J, Brandsma M, Janssen GM, et al. Immunofluorescence studies of human fibroblasts demonstrate the presence of the complex of elongation factor-1 beta gamma delta in the endoplasmic reticulum. J Cell Sci. 1996;109(5):1113–1117. doi:10.1242/jcs.109.5.1113
  • Maruyama T, Nara K, Yoshikawa H, et al. Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells. Clin Exp Immunol. 2007;147(1):164–175. doi:10.1111/j.1365-2249.2006.03249.x
  • Akintade DD, Chaudhuri B. Identification of proteins involved in transcription/translation (eEF 1A1) as an inhibitor of Bax induced apoptosis. Mol Biol Rep. 2020;47(9):6785–6792. doi:10.1007/s11033-020-05736-5
  • Ditzel HJ, Masaki Y, Nielsen H, et al. Cloning and expression of a novel human antibody-antigen pair associated with Felty’s syndrome. Proc Natl Acad Sci U S A. 2000;97(16):9234–9239. doi:10.1073/pnas.97.16.9234
  • Vera M, Pani B, Griffiths LA, et al. The translation elongation factor eEF1A1 couples transcription to translation during heat shock response. Elife. 2014;3:e03164. doi:10.7554/eLife.03164
  • Gu HJ, Gao CB, Gong JL, Li XJ, Bo SU, Li XN. Comparative proteomic analysis in left ventricular remodeling following myocardial infarction in rats. Biomed Environ Sci. 2012;25(1):117–123.
  • Grassi G, Scaggiante B, Farra R, et al. The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie. 2007;89(12):1544–1552. doi:10.1016/j.biochi.2007.07.007
  • Chen S-L, Lu S-X, Liu L-L, et al. eEF1A1 overexpression enhances tumor progression and indicates poor prognosis in hepatocellular carcinoma. Transl Oncol. 2018;11(1):125–131. doi:10.1016/j.tranon.2017.11.001
  • Bao Y, Zhao TL, Zhang ZQ, et al. High eukaryotic translation elongation factor 1 alpha 1 expression promotes proliferation and predicts poor prognosis in clear cell renal cell carcinoma. Neoplasma. 2020;67(1):78–84. doi:10.4149/neo_2019_190224N158
  • Kim J, Kim J, Yoon N, et al. Expression of EEF1A1 is associated with prognosis of patients with colon adenocarcinoma. J Clin Med. 2019;8(11):1903. doi:10.3390/jcm8111903
  • Lin CY, Beattie A, Baradaran B, et al. Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress. Sci Rep. 2018;8(1):13904. doi:10.1038/s41598-018-32272-x
  • Li X, Chen N, Zhou L, et al. Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer. Am J Cancer Res. 2019;9(4):714–729.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102. doi:10.1093/nar/gkx247
  • Xu J, Ji L, Ruan Y, et al. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma. Signal transduction and targeted therapy. 2021;6(1):1–13. doi:10.1038/s41392-021-00594-4
  • Liu H, Xu Y, Zhang Q, et al. Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer. Surg Oncol. 2017;26(1):13–20. doi:10.1016/j.suronc.2016.12.003
  • Pfeifer A, Hofmann A. Lentiviral Transgenesis, in Gene Knockout Protocols. Springer; 2009:391–405.
  • Guo H, Zeng D, Zhang H, et al. Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma. Oncogene. 2019;38(11):1802–1814. doi:10.1038/s41388-018-0550-3
  • Liu H, Gong Z, Li K, et al. SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma. J Exp Clin Cancer Res. 2021;40(1):1–16. doi:10.1186/s13046-021-01877-y
  • Zhao H, Liu X, Yu L, et al. Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes. Molecular Therapy-Nucleic Acids. 2021;23:667–681. doi:10.1016/j.omtn.2020.12.024
  • Wang Z, Fang Z, Lu R, et al. MicroRNA-204 potentiates the sensitivity of acute myeloid leukemia cells to arsenic trioxide. Oncol Res. 2019;27(9):1035–1042. doi:10.3727/096504019X15528367532612
  • Chen T, Liu H, Liu Z, et al. FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis. Oncogene. 2021;40:1–13.
  • Taymans J-M, Nkiliza A, Chartier-Harlin M-C. Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson’s disease pathogenesis. Trends Mol Med. 2015;21(8):466–472. doi:10.1016/j.molmed.2015.05.004
  • Abbas W, Kumar A, Herbein G. The eEF1A proteins: at the crossroads of oncogenesis, apoptosis. Front Oncol. 2015;5:75.
  • Lee M-H, Surh Y-J. eEF1A2 as a putative oncogene. Ann N Y Acad Sci. 2009;1171(1):87. doi:10.1111/j.1749-6632.2009.04909.x
  • Lin C-Y, Beattie A, Baradaran B, Dray E, Duijf PH. Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress. Sci Rep. 2018;8(1):1–12.
  • Liu X, Chen L, Ge J, et al. The ubiquitin-like protein FAT10 stabilizes eEF1A1 expression to promote tumor proliferation in a complex manner. Cancer Res. 2016;76(16):4897–4907. doi:10.1158/0008-5472.CAN-15-3118
  • Huang J, Zheng C, Shao J, et al. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway. Biochem Biophys Res Commun. 2017;494(3–4):542–549. doi:10.1016/j.bbrc.2017.10.116
  • Huang Y, Hu JD, Qi YL, et al. [Effect of knocking down eEF1A1 gene on proliferation and apoptosis in Jurkat cells and its mechanisms]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012;20(4):835–841. Chinese.
  • Blanch A, Robinson F, Watson IR, et al. Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. PLoS One. 2013;8(6):e66436. doi:10.1371/journal.pone.0066436
  • Borradaile NM, Buhman KK, Listenberger LL, et al. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell. 2006;17(2):770–778. doi:10.1091/mbc.e05-08-0742
  • Chen E, Proestou G, Bourbeau D, et al. Rapid up-regulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis. Exp Cell Res. 2000;259(1):140–148. doi:10.1006/excr.2000.4952
  • Duttaroy A, Bourbeau D, Wang X-L, et al. Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp Cell Res. 1998;238(1):168–176. doi:10.1006/excr.1997.3819
  • Dapas B, Pozzato G, Zorzet S, et al. Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells. Int J Pharm. 2020;574:118895. doi:10.1016/j.ijpharm.2019.118895
  • Scaggiante B, Farra R, Dapas B, et al. Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects. Int J Pharm. 2016;506(1–2):268–279. doi:10.1016/j.ijpharm.2016.04.031
  • Qi H, Ning L, Yu Z, et al. Proteomic identification of eEF1A1 as a molecular target of curcumol for suppressing metastasis of MDA-MB-231 cells. J Agric Food Chem. 2017;65(14):3074–3082. doi:10.1021/acs.jafc.7b00573
  • Liu S, Hausmann S, Carlson SM, et al. METTL13 methylation of eEF1A increases translational output to promote tumorigenesis. Cell. 2019;176(3):491–504.e21. doi:10.1016/j.cell.2018.11.038